Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Nadia Cambados, Thomas Walther, Karen Nahmod, Johanna M. Tocci, Natalia Rubinstein, Ilka Böhme, Marina Simian, RocÃo Sampayo, Melisa Del Valle Suberbordes, Edith C. Kordon, Carolina Schere-Levy
Published Jul 17, 2017 · Vol. 8, No. 51 · pp. 88475-88487
Sarah Rohde, Tobias Lindner, Stefan Polei, Jan Stenzel, Luise Borufka, Sophie Achilles, Eric Hartmann, Falko Lange, Claudia Maletzki, Michael Linnebacher, Änne Glass, Sarah Marie Schwarzenböck, Jens Kurth, Alexander Hohn, Brigitte Vollmar, Bernd Joachim Krause, Robert Jaster
Published Jul 15, 2017 · Vol. 8, No. 41 · pp. 69756-69767
Jürgen C. Becker, Eva Lorenz, Selma Ugurel, Thomas K. Eigentler, Felix Kiecker, Claudia Pföhler, Ivonne Kellner, Friedegund Meier, Katharina Kähler, Peter Mohr, Carola Berking, Gabriele Haas, Christoph Helwig, Dina Oksen, Dirk Schadendorf, Lisa Mahnke, Murtuza Bharmal
Published Jul 13, 2017 · Vol. 8, No. 45 · pp. 79731-79741
